Home › Funds › BNP PARIBAS › BIIB

BNP PARIBAS position in BIIB

BIOGEN INC · Health Care

BNP PARIBAS reported holding 82,282 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$18.6M, representing 0.45% of its reported portfolio and ranking #43 among its reported holdings. BNP PARIBAS has disclosed BIIB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)82.28K sh
Reported value held$18.59M
Portfolio Weight0.45%
First reportedQ1 2024
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How BNP PARIBAS's BIIB position evolved

BNP PARIBAS first disclosed a stake in BIIB in Q1 2024 at 700 shares (US$151K). The position peaked in Q3 2026 at 82,282 shares, worth US$18.6M. Across 11 filings, BNP PARIBAS increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 82,282 shares valued at US$18.6M — an increase of 77,922 shares quarter over quarter.. Notable position changes include a 523% increase in Q2 2026 (shares rose 5% over the following quarter), a 1787% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 700 $150.97K New
Q2 2024 700 $162.24K Hold
Q3 2024 700 $135.99K Hold
Q4 2024 804 $123.07K Add
Q1 2025 874 $119.63K Add
Q2 2025 804 $100.90K Reduce
Q3 2025 804 $112.65K Hold
Q4 2025 700 $123.25K Reduce
Q1 2026 700 $128.28K Hold
Q2 2026 4.36K $940.66K Add
Q3 2026 82.28K $18.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 21 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has BNP PARIBAS held BIIB?

BNP PARIBAS has disclosed BIIB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is BNP PARIBAS's current position in BIIB?

As of Q3 2026, BNP PARIBAS holds 82.28K shares of BIIB (BIOGEN INC), valued at $18.59M, representing 0.45% of its reported portfolio and ranking #43.

Has BNP PARIBAS been buying or selling BIIB?

In the latest 13F filing (Q3 2026), BNP PARIBAS increased its position in BIIB. The position peaked in Q3 2026 at 82.28K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.